Back
 OJO  Vol.5 No.9 , September 2015
Survival Rates Following Skeletal Metastases—A Twenty-Year Analysis
Abstract: Introduction: The aims of this study were to establish an estimate of the prognosis and to identify the variables predictive of survival following the diagnosis of metastatic bone disease. Materials and Methods: Ninety-seven patients diagnosed with skeletal metastases confirmed by histological examination between 1991 and 2010 were selected. Data were retrospectively collected including age and sex, sites and histology of the primary tumour and skeletal metastases, presence of visceral metastases, pathological fracture, and the treatment received. Results: Ninety-three patients (95.9%) were deceased. The overall rate of survival was 47% at 6 months, 31% at one year and 10% at three years. Multivariate analysis confirmed the grade of malignancy, age and systemic therapy as independent predictors of survival. Discussion and Conclusion: The prognosis of patients with skeletal metastases should be estimated according to the site and histology of the primary tumour, grade of malignancy and age at the time of presentation.
Cite this paper: Ammori, M. , Panchani, S. , Gregory, J. , Wylie, J. and Paul, A. (2015) Survival Rates Following Skeletal Metastases—A Twenty-Year Analysis. Open Journal of Orthopedics, 5, 288-296. doi: 10.4236/ojo.2015.59039.
References

[1]   Hansen, B.H., Keller, J., Laitinen, M., et al. (2004) The Scandinavian Sarcoma Group Skeletal Metastasis Registry. Survival after Surgery for Bone Metastasis in the Pelvis and Extremities. Acta Orthopaedica Scandinavica, 75, 11-15.
http://dx.doi.org/10.1080/00016470410001708270

[2]   Katagiri, H., Takahashi, M., Wakai, K., et al. (2005) Prognostic Factors and a Scoring System for Patients with Skeletal Metastasis. The Journal of Bone & Joint Surgery (British), 87, 698-703.
http://dx.doi.org/10.1302/0301-620X.87B5.15185

[3]   Tomita, K., Kawahara, N., Kobayashi, T., et al. (2001) Surgical Strategy for Spinal Metastases. Spine, 26, 298-306.
http://dx.doi.org/10.1097/00007632-200102010-00016

[4]   Wibmer, C., Leithner, A., Hofmann, G., et al. (2011) Survival Analysis of 254 Patients after Manifestation of Spinal Metastases—Evaluation of Seven Preoperative Scoring Systems. Spine, 36, 1977-1986.
http://dx.doi.org/10.1097/BRS.0b013e3182011f84

[5]   Yong, M., Jensen, A.O., Jacobsen, J.B., et al. (2011) Survival in Breast Cancer Patients with Bone Metastases and Skeletal-Related Events: A Population-Based Cohort Study in Denmark (1999-2007). Breast Cancer Research and Treatment, 129, 495-503.
http://dx.doi.org/10.1007/s10549-011-1475-5

[6]   Brown, J.E., Cook, R.J., Major, P., et al. (2005) Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer and Other Solid Tumours. Journal of the National Cancer Institute, 97, 59-69.
http://dx.doi.org/10.1093/jnci/dji002

[7]   Bickels, J., Dadia, S. and Lidar, Z. (2009) Surgical Management of Metastatic Bone Disease. The Journal of Bone & Joint Surgery (American), 91, 1503-1516.
http://dx.doi.org/10.2106/JBJS.H.00175

[8]   Bohm, P. and Huber, J. (2002) The Surgical Treatment of Bony Metastases of the Spine and Limbs. The Journal of Bone & Joint Surgery (British), 84, 521-529.
http://dx.doi.org/10.1302/0301-620X.84B4.12495

[9]   Wedin, R., Bauer, H.C. and Rutqvist, L.E. (2001) Surgical Treatment for Skeletal Breast Cancer Metastases: A Population-Based Study of 641 Patients. Cancer, 92, 257-262.
http://dx.doi.org/10.1002/1097-0142(20010715)92:2<257::AID-CNCR1317>3.0.CO;2-R

[10]   British Orthopaedic Association and the British Orthopaedic Oncology Society. Metastatic Bone Disease: A Good Guide to Practice.
http://www.spitalmures.ro/_files/protocoale_terapeutice/oncologie/metastatic_bone_disease.pdf

[11]   Campanacci, M. (1999) Bone and Soft Tissue Tumours. 2nd Edition, Springer-Vaerlag, New York.
http://dx.doi.org/10.1007/978-3-7091-3846-5

[12]   Katakami, N. (2006) Lung Cancer with Bone Metastasis. Gan to kagaku ryoho, 33, 1049-1053.

[13]   Ando, M., Ando, Y., Sugiura, S., et al. (1999) Prognostic Factors for Short-Term Survival in Patients with Stage IV Non-Small Cell Lung Cancer. Japanese Journal of Cancer Research, 90, 249-253.
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00740.x

[14]   Decroisette, C., Monnet, I., Berard, H., et al. (2011) Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601). Journal of Thoracic Oncology, 6, 576-582.
http://dx.doi.org/10.1097/JTO.0b013e318206a1e3

[15]   Peng, H., Ma, M. and Han, B. (2011) Survival Analysis of 1,742 Patients with Stage IV Non-Small Cell Lung Cancer. Chinese Journal of Lung Cancer, 14, 362-366.

[16]   Mizumoto, M., Harada, H., Asakura, H., et al. (2011) Radiotherapy for Patients with Metastases to the Spinal Column: A Review of 603 Patients at Shizuoka Cancer Centre Hospital. International Journal of Radiation Oncology*Biology* Physics, 79, 208-213.
http://dx.doi.org/10.1016/j.ijrobp.2009.10.056

[17]   Lee, R.J., Saylor, P.J. and Smith, M.R. (2010) Contemporary Therapeutic Approaches Targeting Bone Complications in Prostate Cancer. Clinical Genitourinary Cancer, 8, 29-36.
http://dx.doi.org/10.3816/CGC.2010.n.005

[18]   Yuasa, T., Urakami, S., Yamamoto, S., et al. (2011) Treatment Outcome and Prognostic Factors in Renal Cell Cancer Patients with Bone Metastasis. Clinical & Experimental Metastasis, 28, 405-411.
http://dx.doi.org/10.1007/s10585-011-9379-7

[19]   Balain, B., Jaiswal, A., Trivedi, J.M., et al. (2013) The Oswestry Risk Index: An Aid in the Treatment of Metastatic Disease of the Spine. The Bone & Joint Journal, 95, 210-216.
http://dx.doi.org/10.1302/0301-620X.95B2.29323

[20]   Tokuhashi, Y., Matsuzaki, H., Oda, H., et al. (2005) A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis. Spine, 30, 2186-2191.
http://dx.doi.org/10.1097/01.brs.0000180401.06919.a5

[21]   Chow, E., Harris, K., Fan, G., et al. (2007) Palliative Radiotherapy Trials for Bone Metastases: A Systematic Review. Journal of Clinical Oncology, 25, 1423-1436.
http://dx.doi.org/10.1200/JCO.2006.09.5281

[22]   Coleman, R.E. (1997) Skeletal Complications of Malignancy. Cancer, 80, 1588-1594.
http://dx.doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G

[23]   Gregory, J.J. and Cool, P. (2012) Skeletal Metastases and Pathological Fractures. In: Sivananthan, S., Sherry, E., Warnke, P. and Miller, M., Eds., Mercer’s Textbook of Orthopaedics and Trauma, 10th Edition, Hodder Arnold, London, 925-939.
http://dx.doi.org/10.1201/b13543-95

[24]   Gregory, J.J., Ockendon, M., Cribb, G.L., et al. (2011) The Outcome of Locking Plate Fixation for the Treatment of Periarticular Metastases. Acta Orthopædica Belgica, 77, 362-370.

 
 
Top